Rosen, D., Fayadat-Dilman, L., Zhang, Y., Dobrenkov, K., Chartash, E., Wnek, R., . . . Beebe, A. M. (2022). Preclinical characterization and clinical translation of pharmacodynamic markers for MK-5890: A human CD27 activating antibody for cancer immunotherapy. BMJ Publishing Group.
Chicago Style (17th ed.) CitationRosen, David, et al. Preclinical Characterization and Clinical Translation of Pharmacodynamic Markers for MK-5890: A Human CD27 Activating Antibody for Cancer Immunotherapy. BMJ Publishing Group, 2022.
MLA (9th ed.) CitationRosen, David, et al. Preclinical Characterization and Clinical Translation of Pharmacodynamic Markers for MK-5890: A Human CD27 Activating Antibody for Cancer Immunotherapy. BMJ Publishing Group, 2022.
Warning: These citations may not always be 100% accurate.